Science Saturday: Mayo's approach to untangling Alzheimer's

Families living with?Alzheimer's disease?woke to devastating newspaper headlines recently: Another highly touted drug failed in clinical trials. Drugmaker Eli Lilly's EXPEDITION3 trial tested an antibody, a molecule used by the immune system to fight off disease, called solanezumab. This experimental drug sought to remove harmful proteins in the brain that become building blocks for amyloid, [...]
Source: Mayo Clinic Research News - Category: Research Source Type: news